GlassScriptPhysician profile
William F Wiley
NPI 1689687147
$479,195.54
in general payments reported to CMS, 2019-2025
37 companies · $42K in 2025
The $42K reported for 2025 was more than what 98% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $61K · 2020: $48K · 2021: $27K · 2022: $107K · 2023: $121K · 2024: $73K · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $158K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $58K · Education: $11K · Food and Beverage: $8,276 · Travel and Lodging: $1,320 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $250 · Gift: $36.06 · Honoraria: $32.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $158,027.33 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $57,945.43 |
| Education | $10,505.18 |
| Food and Beverage | $8,275.89 |
| Travel and Lodging | $1,320.38 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $250.00 |
| Gift | $36.06 |
| Honoraria | $32.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $153,370.94 | 2019-2025 | Hydrus Microstent, Acrysof Iq Vivity, Acrysof Iq Panoptix Uv Iol |
| Carl Zeiss Meditec, INC. | $82,336.73 | 2019-2025 | Visumax, Iolmaster 700, Humphrey Hfa |
| Beaver-Visitec International, INC. | $60,569.58 | 2019-2024 | |
| Glaukos Corporation | $54,501.13 | 2019-2025 | Travoprost Intraocular Implant - Idose, Idosetr |
| Rxsight INC | $36,628.10 | 2019-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Johnson & Johnson Surgical Vision, INC. | $19,271.33 | 2019-2025 | Tecnis Iol, One Series Ultra, Amo Phaco Needle |
| Alcon Research LLC | $15,961.21 | 2019-2025 | Centurion, Clareon, Acrysof Iq Panoptix Uv Iol |
| Carl Zeiss Meditec USA, INC. | $13,180.16 | 2021-2025 | Visumax, Mel 90, Quatera 700 |
| Bausch & Lomb Americas INC. | $12,578.78 | 2022-2025 | Ic-8 Apthera Iol, Miebo, Xiidra |
| Nova Eye, INC. | $6,825.00 | 2024 | |
| Rayner Intraocular Lenses Limited | $5,490.00 | 2021-2025 | Rayone Aspheric, Rayone Emv, Rayone Spheric |
| New World Medical,INC. | $4,430.98 | 2019-2022 | |
| Lensar, INC. | $2,245.04 | 2019-2025 | Lensar Laser System |
| Hoya Surgical Optics, INC | $2,000.00 | 2023 | Vivinex Gemetric |
| Aerie Pharmaceuticals, INC. | $1,558.80 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $1,513.13 | 2019-2020 | |
| Ivantis, INC | $1,493.03 | 2019-2021 | |
| Allergan, INC. | $1,274.14 | 2020-2021 | |
| Harrow Eye, LLC | $1,145.79 | 2023-2025 | Iheezo, Triesence |
| Kerecis Limited | $692.44 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Abbvie INC. | $600.88 | 2022-2025 | Durysta, Vuity |
| Sight Sciences, INC. | $342.48 | 2019-2024 | Omni Surgical System |
| Dompe US, INC. | $251.61 | 2022 | |
| Carl Zeiss Meditec Cataract Technology INC. | $198.06 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $181.69 | 2019-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $140.97 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $139.91 | 2024 | Tecnis Simplicity |
| Staar Surgical Company | $52.70 | 2019 | |
| Medline Industries LP | $48.08 | 2019 | |
| The Cameron-Ehlen Group, INC. | $38.66 | 2019 | |
| Novartis Pharmaceuticals Corporation | $32.71 | 2019-2022 | |
| Eyevance Pharmaceuticals LLC | $32.03 | 2019-2022 | |
| Oyster Point Pharma, INC. | $28.35 | 2023 | Tyrvaya |
| Vantage Technology LLC | $27.48 | 2023 | |
| Amgen INC. | $13.62 | 2025 | Tepezza |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$132,948.69 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$82,386.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Wiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.